BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36606103)

  • 21. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
    Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
    Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parapneumonic effusions and empyema.
    Light RW
    Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behaviour of nucleated cells in various types of pleural effusion.
    Ferreiro L; Pereiro T; San José E; Toubes ME; Suárez-Antelo J; Álvarez Dobaño JM; González Barcala FJ; Rodríguez Núñez N; Lama A; Valdés L
    Rev Clin Esp (Barc); 2017 Apr; 217(3):136-143. PubMed ID: 28215651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.
    Sharma A; Agrawal A; Sindhwani G; Sharma A; Tomo S; Charan J; Yadav D; Sharma P
    Pleura Peritoneum; 2021 Jun; 6(2):83-90. PubMed ID: 34179342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The etiology of pleural effusions in an area with high incidence of tuberculosis.
    Valdés L; Alvarez D; Valle JM; Pose A; San José E
    Chest; 1996 Jan; 109(1):158-62. PubMed ID: 8549179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of common investigations in aetiological evaluation of exudative pleural effusions.
    Maji A; Maikap MK; Jash D; Saha K; Kundu A; Saha D; Banerjee S; Patra A
    J Clin Diagn Res; 2013 Oct; 7(10):2223-6. PubMed ID: 24298481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between parapneumonic effusion and pericardial effusion in a pediatric cohort.
    Roberts JE; Bezack BJ; Winger DI; Pollack S; Shah RA; Cataletto M; Katz DS; Montoya-Iraheta C; Schroeder SA; Quintos-Alagheband ML
    Pediatrics; 2008 Dec; 122(6):e1231-5. PubMed ID: 18984649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vascular endothelial growth factor in benign and malignant pleural effusions].
    Kaya A; Poyraz B; Celik G; Ciledag A; Gulbay BE; Savas H; Savas I
    Arch Bronconeumol; 2005 Jul; 41(7):376-9. PubMed ID: 16029730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronic acid levels are increased in complicated parapneumonic pleural effusions.
    Zaga T; Makris D; Tsilioni I; Kiropoulos T; Oikonomidi S; Damianos A; Gourgoulianis KI
    Monaldi Arch Chest Dis; 2011 Sep; 75(3):167-71. PubMed ID: 22428219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of pleural effusions.
    Light RW
    J Formos Med Assoc; 2000 Jul; 99(7):523-31. PubMed ID: 10925561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
    Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Profile of Patients Presenting with Malignant Pleural Effusion to a Tertiary Health Care Centre.
    Gadewad N; Deokar K; Ghorpade S
    J Assoc Physicians India; 2017 Aug; 65(8):28-31. PubMed ID: 28799302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta-1 level in pleural effusion.
    Ceyhan BB; Demiralp E; Karakurt ZL; Karakurt S; Sungur M
    Respirology; 2003 Sep; 8(3):321-5. PubMed ID: 12911825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Diagnostic Value of the Pleural Fluid C-Reactive Protein in Parapneumonic Effusions.
    Izhakian S; Wasser WG; Fox BD; Vainshelboim B; Kramer MR
    Dis Markers; 2016; 2016():7539780. PubMed ID: 27194820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic approach to pleural effusion.
    Saguil A; Wyrick K; Hallgren J
    Am Fam Physician; 2014 Jul; 90(2):99-104. PubMed ID: 25077579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pleural effusion in long-term hemodialysis patients.
    Bakirci T; Sasak G; Ozturk S; Akcay S; Sezer S; Haberal M
    Transplant Proc; 2007 May; 39(4):889-91. PubMed ID: 17524841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transudative malignant pleural effusions: prevalence and mechanisms.
    Ashchi M; Golish J; Eng P; O'Donovan P
    South Med J; 1998 Jan; 91(1):23-6. PubMed ID: 9438397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of interleukin-6, gamma interferon and adenosine deaminase markers in management of pleural effusion patients.
    Marie MA; John J; Krishnappa LG; Gopalkrishnan S; Bindurani SR; Cs P
    West Indian Med J; 2013 Dec; 62(9):803-7. PubMed ID: 25117385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uremic pleuritis in chronic hemodialysis patients.
    Rashid-Farokhi F; Pourdowlat G; Nikoonia MR; Behzadnia N; Kahkouee S; Nassiri AA; Masjedi MR
    Hemodial Int; 2013 Jan; 17(1):94-100. PubMed ID: 22716271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.